Tobiasson, Magnus
I. Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor resistant, low- and Int-1 risk MDS. Results from the nordic NMDSG08A phase II study. M Tobiasson, I Dybedahl, M Skov Holm, M Karimi, L Brandefors, H Garelius, M Grövdal, I Högh-Dufva, K Grønbæk, M Jansson, C Marcher, L Nilsson, A Olsnes Kittang, A Porwit, L Saft, L Möllgård, E Hellström-Lindberg. Blood Cancer J. Mar 2014; 4(3): e189. ::doi::10.1038/bcj.2014.8 ::pmid::24608733 ::isi::000334494800001.  , 2015